Logo image of EPIX

ESSA Pharma Inc (EPIX) Stock Price, Forecast & Analysis

USA - NASDAQ:EPIX - CA29668H7085 - Common Stock

0.2012 USD
0 (-1.85%)
Last: 10/8/2025, 8:00:02 PM
0.1951 USD
-0.01 (-3.03%)
After Hours: 10/8/2025, 8:00:02 PM

EPIX Key Statistics, Chart & Performance

Key Statistics
Market Cap9.52M
Revenue(TTM)N/A
Net Income(TTM)-25.12M
Shares47.31M
Float44.65M
52 Week High6.45
52 Week Low0.18
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-0.64
PEN/A
Fwd PEN/A
Earnings (Next)12-15 2025-12-15/amc
IPO2021-02-22
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology


EPIX short term performance overview.The bars show the price performance of EPIX in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -20 -40 -60 -80

EPIX long term performance overview.The bars show the price performance of EPIX in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of EPIX is 0.2012 USD. In the past month the price decreased by -1.85%. In the past year, price decreased by -96.77%.

ESSA Pharma Inc / EPIX Daily stock chart

EPIX Latest News, Press Relases and Analysis

EPIX Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 23.83 397.78B
AMGN AMGEN INC 15.48 182.21B
GILD GILEAD SCIENCES INC 14.96 152.07B
VRTX VERTEX PHARMACEUTICALS INC 24.72 110.05B
REGN REGENERON PHARMACEUTICALS 14.99 71.50B
ALNY ALNYLAM PHARMACEUTICALS INC 886.18 59.24B
INSM INSMED INC N/A 40.94B
NTRA NATERA INC N/A 28.37B
BIIB BIOGEN INC 9.53 23.39B
INCY INCYTE CORP 16.85 21.12B
UTHR UNITED THERAPEUTICS CORP 17.4 20.77B
NBIX NEUROCRINE BIOSCIENCES INC 35.24 14.61B

About EPIX

Company Profile

EPIX logo image ESSA is a pharmaceutical company focused on the development of small molecule drugs for the treatment of cancer, with a focus on advanced prostate cancer. The company is headquartered in Vancouver, British Columbia and currently employs 35 full-time employees. The company went IPO on 2021-02-22. The firm is undergoing a comprehensive review process to review its strategic options to maximize shareholder value.

Company Info

ESSA Pharma Inc

999 West Broadway, Suite 720

Vancouver BRITISH COLUMBIA V5Z 1K5 CA

CEO: David Parkinson

Employees: 35

EPIX Company Website

EPIX Investor Relations

Phone: 17783310962

ESSA Pharma Inc / EPIX FAQ

What does ESSA Pharma Inc do?

ESSA is a pharmaceutical company focused on the development of small molecule drugs for the treatment of cancer, with a focus on advanced prostate cancer. The company is headquartered in Vancouver, British Columbia and currently employs 35 full-time employees. The company went IPO on 2021-02-22. The firm is undergoing a comprehensive review process to review its strategic options to maximize shareholder value.


What is the stock price of ESSA Pharma Inc today?

The current stock price of EPIX is 0.2012 USD. The price decreased by -1.85% in the last trading session.


Does ESSA Pharma Inc pay dividends?

EPIX does not pay a dividend.


What is the ChartMill technical and fundamental rating of EPIX stock?

EPIX has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


Where is ESSA Pharma Inc (EPIX) stock traded?

EPIX stock is listed on the Nasdaq exchange.


When does ESSA Pharma Inc (EPIX) report earnings?

ESSA Pharma Inc (EPIX) will report earnings on 2025-12-15, after the market close.


EPIX Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

EPIX Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to EPIX. EPIX has a great financial health rating, but its profitability evaluates not so good.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

EPIX Financial Highlights

Over the last trailing twelve months EPIX reported a non-GAAP Earnings per Share(EPS) of -0.64. The EPS decreased by -6.67% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -22.73%
ROE -23.07%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%46.72%
Sales Q2Q%N/A
EPS 1Y (TTM)-6.67%
Revenue 1Y (TTM)N/A

EPIX Forecast & Estimates

7 analysts have analysed EPIX and the average price target is 1.73 USD. This implies a price increase of 761.83% is expected in the next year compared to the current price of 0.2012.


Analysts
Analysts45.71
Price Target1.73 (759.84%)
EPS Next Y-13.16%
Revenue Next YearN/A

EPIX Ownership

Ownership
Inst Owners73.7%
Ins Owners2.08%
Short Float %N/A
Short RatioN/A